Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients
Bloomfield, Daniel, MD, Carlson, Gary L., BS, Sapre, Aditi, PhD, Tribble, Diane, PhD, McKenney, James M., Pharm D, Littlejohn, Thomas W., MD, Sisk, Christine McCrary, BS, Mitchel, Yale, MD, Pasternak, Richard C., MD
Published in The American heart journal (01.02.2009)
Published in The American heart journal (01.02.2009)
Get full text
Journal Article
Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension
Littlejohn, 3rd, Thomas W, Trenkwalder, Peter, Hollanders, Geert, Zhao, Yanxing, Liao, Weichi
Published in Current medical research and opinion (01.04.2009)
Published in Current medical research and opinion (01.04.2009)
Get more information
Journal Article
Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia
Dansky, Hayes M., MD, Bloomfield, Daniel, MD, Gibbons, Patrice, MS, Liu, Sherry, MS, Sisk, Christine McCrary, BS, Tribble, Diane, PhD, McKenney, James M., PharmD, Littlejohn, Thomas W., MD, Mitchel, Yale, MD
Published in The American heart journal (01.10.2011)
Published in The American heart journal (01.10.2011)
Get full text
Journal Article
A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension
Gleim, Gilbert W., Rubino, Joseph, Zhang, Hongyan, Shahinfar, Shahnaz, Soffer, Beth A., Lyle, Paulette A., Littlejohn, Thomas W., Feig, Peter U.
Published in Clinical therapeutics (01.10.2006)
Published in Clinical therapeutics (01.10.2006)
Get full text
Journal Article
Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study
Littlejohn, 3rd, Thomas W, Majul, Claudio R, Olvera, R, Seeber, Mary, Kobe, Maureen, Guthrie, Robert, Oigman, Wille
Published in Postgraduate medicine (01.03.2009)
Published in Postgraduate medicine (01.03.2009)
Get more information
Journal Article
Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapy
Shepherd, James, Packard, Chris, III, Thomas W. Littlejohn, Walker, James, Stein, Evan A., Smith, Karen, Kallend, David, Blasetto, James W.
Published in Current medical research and opinion (01.10.2004)
Published in Current medical research and opinion (01.10.2004)
Get full text
Journal Article